Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Actidione
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
Vandetanib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Salifungin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Celecoxib
Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/25/2020
Nanchangamycin
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
X-206
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
Sertraline 
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Digoxin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Lanatoside C
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Ouabain
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
4-Chloro-N-(1-methyl-1H-benzimidazol-5-yl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020
4-{[5-(2-Nitrophenyl)-2-furyl] methylene}-3-phenyl-5(4H)-isoxazolone
Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020
mRBD
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/23/2020
Callophycin A
Potential treatment - theoretical effect Natural product Antiviral Nov/21/2020
Luminol sodium salt
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/20/2020
NRICM101
Potential treatment - clinical evidence Natural product Other treatment Nov/19/2020
C135-LS/C144-LS
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/19/2020
C135-LS/C121-LS
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/19/2020
EGYVIR
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/18/2020
Calcitriol
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/18/2020